STOCK TITAN
  1. Home
  2. News
  3. QSI

Quantum-Si Incorporated - QSI STOCK NEWS

Welcome to our dedicated page for Quantum-Si Incorporated news (Ticker: QSI), a resource for investors and traders seeking the latest updates and insights on Quantum-Si Incorporated stock.

Quantum-Si Incorporated (symbol: QSI) is revolutionizing the field of proteomics with cutting-edge technologies. The company has developed a unique semiconductor chip that enables single-molecule, next-generation protein sequencing and genomics, going beyond traditional DNA sequencing. This innovation is set to digitize proteomic research, significantly advancing drug discovery and diagnostics.

Founded by successful entrepreneurs and fully funded to focus on groundbreaking science, Quantum-Si fosters an environment where highly committed individuals are encouraged to solve tough problems and create impactful technologies. The company is headquartered in Guilford, Connecticut, and continues to attract bright minds dedicated to transforming healthcare.

Quantum-Si's core products include a suite of technologies that leverage their proprietary semiconductor chip for high-precision protein analysis. These products are designed to provide deeper insights into the proteome, which is essential for understanding diseases, developing new therapies, and personalizing medicine.

Recent achievements highlight Quantum-Si's commitment to innovation and excellence. The company has formed strategic partnerships with leading research institutions and pharmaceutical companies to accelerate the adoption of its technologies. Additionally, Quantum-Si continues to invest in research and development to enhance its product offerings and expand its market reach.

Financially, Quantum-Si is backed by substantial funding from its founders, allowing the company to prioritize innovation and market entry without the immediate pressures of profitability. This financial stability ensures that the company can focus on long-term goals and sustainable growth.

For those interested in joining a dynamic and innovative team, Quantum-Si offers a range of career opportunities. Visit their job postings at 4Catalyzer to learn more about current openings.

Empower discovery. Empower health. Empower you.

News

Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) appoints Paula Dowdy, a seasoned executive with 35+ years of experience, to its Board of Directors. Dowdy's expertise in life sciences and technology industries, including roles at Illumina and Cisco Systems, brings valuable insights to Quantum-Si's growth strategy and global operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.79%
Tags
management
-
News

Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference

Rhea-AI Summary
Quantum-Si Incorporated (NASDAQ: QSI) will showcase its Next-Generation Protein Sequencing instrument, Platinum, and recent enhancements at the 20th Anniversary US HUPO Conference. Researchers will present data from Platinum, demonstrating deeper insights into proteins. Justyna Fert-Bober and Kenneth Skinner will lead a Breakfast Seminar on Next-Generation Protein Sequencing and Mass Spectrometry. Quantum-Si aims to bring single-molecule proteomics to labs worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.81%
Tags
none
-
News

Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results

Rhea-AI Summary
Quantum-Si Inc. (QSI) announces financial results for Q4 2023, with revenue of $400,000. The Company is finalizing commercial readiness for a full commercial launch by Q1 2024. They have launched a new sequencing kit and added a third international distribution partner. Full year 2024 financial guidance has been provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.78%
Tags
earnings
News

Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar

Rhea-AI Summary
Esteemed scientist Dr. Christopher Mason of Weill Cornell Medicine will discuss his Two Frontiers Project using Quantum-Si's protein sequencer, Platinum®, in an exclusive webinar hosted by GenomeWeb. The focus is on expanding multiomic research on extremophiles and understanding human survival in extreme environments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.36%
Tags
none
-
News

Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) will report financial results for Q4 and full year 2023 on February 29, 2024. The Company will host a conference call to discuss financial results and provide a business update on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.94%
Tags
conferences earnings
-
News

Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has announced the launch of new platform enhancements for Platinum®, with the release of its new V2 Sequencing Kits. The enhancements include increased sequencing performance, the ability to identify unknown proteins, high reproducibility across runs, and a 3-fold reduction in cost per amino acid. These improvements aim to make protein sequencing more accessible and cost-efficient for researchers, catering to the evolving needs of a diverse customer base.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.97%
Tags
none
News

Quantum-Si Introduces World’s First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has announced a new distribution agreement with TOMY Digital Biology Co., Ltd. to make its protein sequencing instrument, Platinum®, available in Japan. This partnership will enable Japanese researchers to access Quantum-Si's next-generation protein sequencer™ and associated consumables, marking a significant step forward in scientific innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
none
-
News

Quantum-Si Expands Global Reach with Addition of New Distributor

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has entered into an agreement with a new international distributor, 3Genes Distribution a.s., to distribute its next-generation protein sequencing instrument, Platinum, across Eastern Europe. This strategic move follows a previous agreement with ELTA 90 to distribute Platinum in Southeast Europe, reflecting the company's mission to revolutionize proteomics and expand its global reach.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
none
-
News

Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows

Rhea-AI Summary
Quantum-Si Incorporated (Nasdaq: QSI) has announced a distribution agreement with Elta 90 to distribute its Platinum™ instrument and consumables in Southeast Europe. This partnership aims to meet the growing demand for next-generation protein sequencing™ platform, which offers single-molecule amino acid resolution. The agreement is expected to accelerate scientific research and expand the field of proteomics, making the technology more accessible to scientists in every lab, everywhere.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.75%
Tags
none
News

Quantum-Si Reports Third Quarter 2023 Financial Results

Rhea-AI Summary
Quantum-Si (Nasdaq: QSI) announced financial results for Q3 2023, recording revenue of $223,000 and gross profit of $108,000. The Company completed a strategic review of R&D programs and organizational design, presented first customer data, and added an independent director to the Board. The Company expects full year 2023 adjusted total operating expenses to be approximately $100 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.77%
Tags
earnings

FAQ

What is the current stock price of Quantum-Si Incorporated (QSI)?

The current stock price of Quantum-Si Incorporated (QSI) is $1.62 as of November 22, 2024.

What is the market cap of Quantum-Si Incorporated (QSI)?

The market cap of Quantum-Si Incorporated (QSI) is approximately 172.7M.

What does Quantum-Si Incorporated do?

Quantum-Si specializes in proteomics, using semiconductor technology for next-generation protein sequencing and genomics.

What is the significance of Quantum-Si's semiconductor chip?

The chip enables single-molecule protein sequencing, advancing drug discovery and diagnostics beyond traditional DNA sequencing.

Where is Quantum-Si headquartered?

Quantum-Si is headquartered in Guilford, Connecticut.

Who funds Quantum-Si?

The company is fully funded by its successful founders.

What are Quantum-Si's core products?

Their core products include technologies that use their proprietary semiconductor chip for high-precision protein analysis.

What recent achievements has Quantum-Si made?

Recent achievements include strategic partnerships with leading research institutions and continued investment in R&D.

What opportunities are available at Quantum-Si?

Quantum-Si offers various career opportunities. Visit their job postings at 4Catalyzer for more details.

How does Quantum-Si contribute to healthcare?

Quantum-Si's technologies provide deeper insights into the proteome, essential for understanding diseases and developing new therapies.

What is the financial condition of Quantum-Si?

Quantum-Si is financially stable, backed by substantial funding from its founders, allowing focus on long-term growth.

How can I stay updated with the latest news about Quantum-Si?

You can stay updated with the latest news on Quantum-Si by visiting their section on StockTitan or their official website.

Stock QSI logo
Quantum-Si Incorporated

Nasdaq:QSI

QSI Rankings

#3978 Ranked by Market Cap
N/A Ranked by Dividends

QSI Stock Data

172.68M
97.95M
19.85%
36.12%
4.15%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States of America
BRANFORD